{"id":5153,"date":"2025-07-25T10:40:58","date_gmt":"2025-07-25T03:40:58","guid":{"rendered":"https:\/\/hataphar.com.vn\/?p=5153"},"modified":"2025-07-25T10:40:58","modified_gmt":"2025-07-25T03:40:58","slug":"meeting-between-askas-bod-and-hataphars-key-personnel","status":"publish","type":"post","link":"https:\/\/hataphar.com.vn\/en\/meeting-between-askas-bod-and-hataphars-key-personnel\/","title":{"rendered":"MEETING BETWEEN ASKA’S BOD AND HATAPHAR’S KEY PERSONNEL"},"content":{"rendered":"

On the morning of July 22nd, a meeting was held at the 6th-floor auditorium of 10A Quang Trung Office, Ha Dong, between the BOD of ASKA Pharmaceutical Holdings Company (Japan) and key personnel of HATAPHAR.<\/strong><\/em><\/p>\n

\"\"<\/p>\n

Attending the conference from ASKA were: Mr. Sohta Yamaguchi – Board Member, CEO of ASKA; Mr. Hiroyasu Nishioka – Board Member of ASKA, Board Member of HATAPHAR; and Mr. Keisuke Oshio – Head of International Business Department, ASKA, Board Member of HATAPHAR. From Hataphar, the Board of Directors and all key management personnel of the company participated.<\/span><\/p>\n

To kick off the program, the conference featured an <\/span>impressive introduction to ASKA Pharmaceutical Holdings Company<\/b>. With over a century of development since 1920, ASKA has solidified its position as one of the <\/span>top 20 pharmaceutical companies in Japan<\/b>. The presentation delved into ASKA’s business philosophy, “Contributing to human health and the advancement of pharmaceutical science,” and highlighted its core strengths in internal medicine, obstetrics\/gynecology, and urology. Breakthrough achievements in research and development, along with a strong presence in both domestic and international markets, underscored ASKA’s capabilities and reputation.<\/span><\/p>\n

\"\"<\/p>\n

Following this, representatives from Hataphar’s leadership provided a detailed presentation on the company’s <\/span>medium and long-term strategic vision<\/b>. To become one of Vietnam’s leading pharmaceutical companies, Hataphar is focusing on key development directions: modernizing production, developing high-quality products, expanding its distribution system, and strengthening its brand position.<\/span><\/p>\n

\"\"<\/p>\n

The core of the conference was an <\/span>open and constructive discussion<\/b>, where the leadership from both sides emphasized their commitment to a deep and comprehensive cooperative relationship. Both ASKA and Hataphar leadership shared the understanding that this collaboration would create <\/span>tremendous synergy<\/b>. This synergy comes from combining ASKA’s international management experience, advanced production technology, and superior R&D capabilities with Hataphar’s deep understanding of the domestic market, solid production foundation, and extensive distribution network. This forms a strong foundation for both companies to jointly research, develop, produce, and introduce high-quality, safe, and effective pharmaceutical products to the Vietnamese market, best serving community healthcare and protection.<\/span><\/p>\n

\"\"<\/p>\n

The meeting between ASKA and Hataphar concluded successfully. This event marks a significant milestone, further <\/span>strengthening the strategic partnership<\/b> and fostering mutual trust and understanding.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

On the morning of July 22nd, a meeting was held at the 6th-floor auditorium of 10A Quang Trung Office, Ha Dong, between the BOD of ASKA Pharmaceutical Holdings Company (Japan) and key personnel of HATAPHAR. Attending the conference from ASKA were: Mr. Sohta Yamaguchi – Board Member, CEO of ASKA; Mr. Hiroyasu Nishioka – Board […]\n","protected":false},"author":1,"featured_media":5145,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[134,144],"tags":[],"class_list":["post-5153","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-events","category-general-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/posts\/5153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/comments?post=5153"}],"version-history":[{"count":1,"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/posts\/5153\/revisions"}],"predecessor-version":[{"id":5154,"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/posts\/5153\/revisions\/5154"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/media\/5145"}],"wp:attachment":[{"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/media?parent=5153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/categories?post=5153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hataphar.com.vn\/en\/wp-json\/wp\/v2\/tags?post=5153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}